Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF3706

Introduced
2/19/26  

Caption

Prior authorization of drugs the enrollee has been prescribed prohibition for at least six months

Impact

If enacted, SF3706 will have a significant impact on health insurance practices in Minnesota. It will align the state's health insurance policies with best practices in patient care by ensuring that once a medication has been established as necessary for the patient's health over a substantial period, insurance companies cannot impose additional authorizations, which can often be time-consuming and inconvenient. The bill will potentially increase compliance with federal guidelines related to preventive care and treatment access, especially in critical areas like mental health and cancer treatment.

Summary

SF3706 is a bill introduced in Minnesota that addresses the prior authorization requirements imposed by health insurance plans for specific medical services and prescription drugs. The bill specifically prohibits prior authorization for medications that an enrollee has been prescribed and used for at least six months, thereby streamlining access to essential pharmaceuticals for patients who have been stable on those medications. This regulation aims to protect patients from unnecessary bureaucratic delays that can hinder their ability to receive timely and effective medical treatment.

Contention

The bill may face challenges from insurance companies, who may argue that the inability to require prior authorizations for medications could lead to higher costs and increased risk of over-prescription. These entities might express concerns about profitability and managing healthcare expenditures without the ability to review treatment necessity. However, proponents of SF3706 contend that alleviating prior authorization requirements will empower patients and encourage better treatment adherence, ultimately leading to better health outcomes and potentially lowering costs associated with emergency care and hospitalizations due to medication non-compliance.

Companion Bills

MN HF3869

Similar To Prior authorization of drugs the enrollee has been prescribed prohibited for at least six months.

Previously Filed As

MN HF3869

Prior authorization of drugs the enrollee has been prescribed prohibited for at least six months.

MN SF3306

Prior authorization on medications prescribed for antineoplastic cancer treatment prohibition; prior authorization denials based on timing of the provided health care service prohibition; expedited prior authorization review for prescriptions that have previously been authorized or covered requirement

MN SF205

Antineoplastic cancer treatment prior authorization prohibition

MN SF731

Prior authorization prohibition for services resulting in health plan company liability equal to or less than $100

MN SF1739

Prior authorization commission establishment

MN HF4801

Provisions governing prior authorization of health care services modified, and managed care contracts under medical assistance modified.

MN SB811

Specifies that prior authorizations for drugs prescribed to manage a chronic condition shall not be revoked or modified within 13 months

MN HB2250

Prior authorizations; habilitative services

MN SF3822

Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance

MN SB39

Add Classes To Prior Authorization Drugs

Similar Bills

No similar bills found.